Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

Clinical trial NCT03391869 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03391869
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Adenocarcinoma Lung Non-Small Cell Carcinoma Stage IV Lung Cancer AJCC v8

Start date: 2017-12-29
Primary completion: 2027-03-31
Enrollment: 339

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.